Nationwide Observation Study to Evaluate the Efficacy and Tolerance of the Adjustable Medical Device REMEEX® in the Treatment of Male Stress Urinary Incontinence

Inclusion Criteria: * The patient has been informed about the study * The patient is at least 18 years old * Patient suffering from moderate stress incontinence (pure or predominant) following radical prostatectomy surgery, for at least 12 months, unresolved after of pelvic floor reeducation * Patient scheduled for REMEEX® implant Exclusion Criteria: * It proves impossible to give the patient clear information * Patient refuses to participate * Life expectancy of the patient estimated to be less than the 5 year follow-up * Impossible to contact patient after hospitalization * Radiotherapy of less than 6 month * Patient unable to fill in questionnaire * Incapably of performing pad test at 24 hours * Recurrent symptomatic prostate cancer * Mixed incontinence with urgency incontinence * Bladder outlet obstruction: stenosis of the vesico-urethral anastomosis or untreated urethral stricture. * Post void residual \>100ml * Other cancer under treatment or progressing * Kidney injury, hepatocellular insufficiency * Auto-immune disease * Neurological-origin urinary incontinence (stroke, MS, Parkinson's) * Incontinence arising from surgery other than prostatectomy * recurrent gross hematuria * Recurrent urinary infection * Bladder stones